Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495157 · ClinicalTrials.gov registry record · Phase 3
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 342
- Enrollment target
NCT00495157 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 342 participants.
The verdict
NCT00495157, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 342 participants
- Enrollment target
Study Summary
Asthma can be effectively controlled using inhaled corticosteroid medication. Treatment with inhaled corticosteroids often requires periodic adjustments to medication dosing and frequency levels. This study examines whether it is more beneficial to adjust corticosteroid treatment based on asthma symptoms and/or biomarkers of lung function versus standard medical guidelines.
Interventions
- BEHAVIORAL Symptom-based adjustment
- BEHAVIORAL Biomarker-based adjustment
- BEHAVIORAL Guideline-based adjustment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495157
The ClinicalTrials.gov registry entry for NCT00495157 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Symptom-based adjustment is the first listed.
NCT00495157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495157 about?
NCT00495157 is a clinical study titled "Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)". Asthma can be effectively controlled using inhaled corticosteroid medication. Treatment with inhaled corticosteroids often requires periodic adjustments to medication dosing and frequency levels. This study examines whether it is more beneficial to adjust corticosteroid treatment based on asthma sym...
What is the current status of trial NCT00495157?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 342 participants. The study started on 2007-06. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00495157?
The interventions under investigation include: Symptom-based adjustment (BEHAVIORAL), Biomarker-based adjustment (BEHAVIORAL), Guideline-based adjustment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00495157?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.